Evidence map›Paper›PMID 18625847›Full record

ArticleThe Journal of cell biology2008

BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways.

Dominique Kranz, Christoph Dohmesen, Matthias Dobbelstein

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Exploiting replicative stress to treat cancer.Nature reviews. Drug discovery · 2015
    Review
  10. Article
  11. Article
  12. Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Connecting chromatin modifying factors to DNA damage response.International journal of molecular sciences · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Dominique KranzMedical Biotechnology Center, Institute for Medical Biology, University of Southern Denmark, 5000 Odense C, Denmark.
Christoph Dohmesen
Matthias Dobbelstein
University of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The histone acetyltransferase Tip60 regulates the apoptotic response to ultraviolet (UV) irradiation. A previously suggested mechanism for this regulation consists of the ability of Tip60 to coactivate transcription by the tumor suppressor p53. In this study, we show that Tip60 is required for the early DNA damage response (DDR) to UV, including the phosphorylation of histone 2AX, c-Jun N-terminal kinases (JNKs), and ataxia telangiectasia-related substrates. In contrast, p53 was not required for UV-induced DDR. Rather, p53 accumulation by either knockdown of Mdm2 or addition of an Mdm2 inhibitor, Nutlin-3, before irradiation strongly attenuated the UV-induced DDR and increased cell survival. This protective effect of preaccumulated p53 was mediated, at least in part, by the increased expression of CDKN1A/p21, subsequent down-regulation of BRCA1, and impaired JNK activation accompanied by decreased association of replication protein A with chromatin. We conclude that Tip60 enables UV-induced DDR signaling even in the absence of p53, whereas preaccumulated p53 suppresses UV-induced DDR by reducing the levels of BRCA1.

Indexed as

Ultraviolet RaysAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinCell Cycle ProteinsCell DeathCell Line, TumorCyclin-Dependent Kinase Inhibitor p21CytoprotectionDNA DamageHistone AcetyltransferasesHumansImidazolesJNK Mitogen-Activated Protein KinasesKeratinocytesLysine Acetyltransferase 5Models, BiologicalAtaxia Telangiectasia Mutated ProteinsATR protein, humanBRCA1 ProteinCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21Histone AcetyltransferasesImidazolesJNK Mitogen-Activated Protein KinasesKAT5 protein, humanLysine Acetyltransferase 5MDM2 protein, humanMutagensnutlin 3PiperazinesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mdm2Replication Protein ARNA, Small InterferingTumor Suppressor Protein p53

Identifiers

PMID18625847
PMCPMC2447902
OpenAlexW1979146983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.